- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT04918849
WhatsApp in India During the COVID-19 Pandemic
Characterising the Spread of COVID-19 Misinformation Through WhatsApp in India
Digital misinformation has been flagged as a major risk of the 21st century, with an estimated cost of $78 billion to the global economy each year. Given this scope, we propose to characterize how misinformation is spread via messenger platforms (e.g. WhatsApp).
Specifically, we seek to:
- Identify metrics of potential misinformation (Aim 1). This is based on the hypothesis that although message contents are highly private, proxy markers can be used to identify potential misinformation.
- Understand the base-rate by which misinformation is shared via messaging applications (Aim 2). This is founded on the hypothesis that misinformation is endemic on messaging platforms, and thus needs to be documented.
- Identify "super spreaders" responsible for sending and receiving a large volume of misinformation (Aim 3). Here, we hypothesise that a small group of super spreaders are responsible for the bulk of misinformation-sharing on messaging applications.
The thrust of this work aligns with both government priorities and the grant's thematic areas, providing actionable findings that are timely amidst a worldwide surge of misinformation.
Studieöversikt
Status
Betingelser
Studietyp
Inskrivning (Förväntat)
Kontakter och platser
Studiekontakt
- Namn: Jean Liu, PhD
- Telefonnummer: 66013694
- E-post: jeanliu@yale-nus.edu.sg
Studieorter
-
-
-
Singapore, Singapore, 138527
- Rekrytering
- Yale-NUS College
-
Kontakt:
- Jean Liu, PhD
- Telefonnummer: 66013964
- E-post: jeanliu@yale-nus.edu.sg
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- Lived in India for more than 2 years,
- Currently Living in India
- Owns a WhatsApp account
Exclusion Criteria:
- Not currently living in India
- Below the ages of 21
- Has not lived in India for more than 2 years
- does not own a WhatsApp account
- Does not speak English or Hindi
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: Kohort
- Tidsperspektiv: Tvärsnitt
Kohorter och interventioner
Grupp / Kohort |
---|
Community Sample
We plan to recruit a community sample of 1000 from the Indian Population.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
WhatsApp Usage
Tidsram: 1 week, starting from date after baseline survey completion
|
Participants were asked a series of questions daily related to their WhatsApp usage behaviors - in particular, their message-forwarding, personal chat and group chat behaviors.
|
1 week, starting from date after baseline survey completion
|
Changes in fear with regards the COVID-19 situation across 1 week
Tidsram: 1 week, starting from date after baseline survey completion
|
1 item each day on fear specifically of the COVID-19 situation (measured on a 4 point scale: min = 1, max = 4; higher scores indicating greater fear about the outbreak).
|
1 week, starting from date after baseline survey completion
|
Changes in amount of thinking about the COVID-19 situation across 1 week
Tidsram: 1 week, starting from date after baseline survey completion
|
1 item each day on how much they thought about the outbreak that day (measured on a 5 point scale: min = 1, max = 5; higher scores indicating more thinking about the outbreak).
|
1 week, starting from date after baseline survey completion
|
Samarbetspartners och utredare
Sponsor
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Förväntat)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 2020-CERC-001C
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Covid19
-
Anavasi DiagnosticsHar inte rekryterat ännu
-
Ain Shams UniversityRekrytering
-
Israel Institute for Biological Research (IIBR)Avslutad
-
Colgate PalmoliveAvslutad
-
Christian von BuchwaldAvslutad
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdAktiv, inte rekryterande
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitätsspital ZürichAnmälan via inbjudan
-
Alexandria UniversityAvslutad
-
Henry Ford Health SystemAvslutad